DK1438963T3 - Anvendelse af N2O til behandling af post-iskærmiske forringelser af hjerneceller - Google Patents

Anvendelse af N2O til behandling af post-iskærmiske forringelser af hjerneceller

Info

Publication number
DK1438963T3
DK1438963T3 DK04300008T DK04300008T DK1438963T3 DK 1438963 T3 DK1438963 T3 DK 1438963T3 DK 04300008 T DK04300008 T DK 04300008T DK 04300008 T DK04300008 T DK 04300008T DK 1438963 T3 DK1438963 T3 DK 1438963T3
Authority
DK
Denmark
Prior art keywords
ischemic brain
brain cell
cell degradation
vol
treat post
Prior art date
Application number
DK04300008T
Other languages
English (en)
Inventor
Marc Lemaire
Original Assignee
Air Liquide Sante Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide Sante Int filed Critical Air Liquide Sante Int
Application granted granted Critical
Publication of DK1438963T3 publication Critical patent/DK1438963T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK04300008T 2003-01-15 2004-01-06 Anvendelse af N2O til behandling af post-iskærmiske forringelser af hjerneceller DK1438963T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0350002A FR2849779B1 (fr) 2003-01-15 2003-01-15 Utilisation de xenon ou de n2o dans le traitement des deteriorations cellulaires cerebrales post-ischemiques

Publications (1)

Publication Number Publication Date
DK1438963T3 true DK1438963T3 (da) 2007-10-01

Family

ID=32525026

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04300008T DK1438963T3 (da) 2003-01-15 2004-01-06 Anvendelse af N2O til behandling af post-iskærmiske forringelser af hjerneceller

Country Status (9)

Country Link
US (1) US7405241B2 (da)
EP (1) EP1438963B1 (da)
AT (1) ATE366113T1 (da)
CA (1) CA2453053A1 (da)
DE (1) DE602004007304T2 (da)
DK (1) DK1438963T3 (da)
ES (1) ES2289458T3 (da)
FR (1) FR2849779B1 (da)
PT (1) PT1438963E (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637089B2 (en) 2003-04-09 2014-01-28 Osmose, Inc. Micronized wood preservative formulations
SG163438A1 (en) * 2003-04-09 2010-08-30 Osmose Inc Micronized wood preservative formulations
US8435569B2 (en) * 2007-04-30 2013-05-07 Nnoxe Pharmaceutiques Inc. Pharmaceutical composition comprising at least one thrombolytic agent (A) and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
CN110464709A (zh) 2012-08-10 2019-11-19 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
US20160030470A1 (en) 2013-03-15 2016-02-04 The Board Of Regents Of The University Of Texas System Liquids rich in noble gas and methods of their preparation and use
CA3214243A1 (en) * 2021-04-02 2022-10-06 Peter Nagele Compositions and methods for treating treatment-resistant depressive disorders with nitrous oxide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876773A (en) * 1973-05-15 1975-04-08 British Oxygen Co Ltd Gas mixtures containing nitrous oxide
FR2596989B1 (fr) * 1986-04-14 1990-05-18 Air Liquide Produit de radiosensibilisation des tissus biologiques en radiotherapie
AU2789192A (en) * 1991-10-04 1993-05-03 Mallinckrodt Medical, Inc. Gaseous ultrasound contrast agents
RU2072241C1 (ru) * 1995-09-20 1997-01-27 Панина Елена Владимировна Способ формирования дыхательной газовой смеси и аппарат для его осуществления
FR2812197B1 (fr) * 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur

Also Published As

Publication number Publication date
EP1438963B1 (fr) 2007-07-04
ES2289458T3 (es) 2008-02-01
US20040258766A1 (en) 2004-12-23
FR2849779A1 (fr) 2004-07-16
FR2849779B1 (fr) 2006-07-14
PT1438963E (pt) 2007-09-11
DE602004007304D1 (de) 2007-08-16
US7405241B2 (en) 2008-07-29
EP1438963A1 (fr) 2004-07-21
DE602004007304T2 (de) 2008-03-13
ATE366113T1 (de) 2007-07-15
CA2453053A1 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
WO2010009892A8 (en) Compositions for the treatment of pain and/or inflamation
NO20053742L (no) Tri (cyclo)-substituerte amidforbindelser
GB2434983A (en) Methods and compositions for wound healing
WO2007085018A3 (en) Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
DK1758860T3 (da) Mættede og umættede 3-pyridylbenzocykloalkylmethylaminer til behandling af smerter, depressioner og angsttilstande
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
BR0313282A (pt) Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
PL371736A1 (en) Method for administering glp-1 molecules
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
SE0300971D0 (sv) Nitric oxide in treatment of inflammation
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
WO2003015605A3 (en) Use of s-nitrosothiol signaling to treat disordered control of breathing
DK1581235T3 (da) Anvendelse af spongosin (2-methoxyadenosin) til behandling af smerte i særdeleshed hyperalgesi
DK1438963T3 (da) Anvendelse af N2O til behandling af post-iskærmiske forringelser af hjerneceller
MXPA05012320A (es) Tratamientos de trastornos bipolares y sintomas asociados.
SE0004101D0 (sv) New use
NZ519722A (en) Treatment of diabetic ulcers
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
DE60236927D1 (de) Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
RS95304A (en) New combination fortreating airway disorders
SE0301885D0 (sv) New use IV
WO2008060535A3 (en) Use of reversine and analogs for treatment of cancer
WO2006119402A3 (en) C-linked glucoronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth